A61K 31/64
Sulfonylureas
Official title: Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
A61K31/64 (Sulfonylureas) appears on 335 US grants and 519 published applications in this corpus.
Search patents in A61K- Granted patents
- 335
- Published applications
- 519
- Assignees
- 281
- Inventors
- 1,048
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 2 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 1 | 0 |
| 1993 | 8 | 0 |
| 1994 | 2 | 0 |
| 1995 | 3 | 0 |
| 1996 | 2 | 0 |
| 1997 | 7 | 0 |
| 1998 | 5 | 0 |
| 1999 | 14 | 0 |
| 2000 | 21 | 0 |
| 2001 | 32 | 2 |
| 2002 | 7 | 22 |
| 2003 | 12 | 28 |
| 2004 | 7 | 25 |
| 2005 | 5 | 17 |
| 2006 | 4 | 13 |
| 2007 | 6 | 18 |
| 2008 | 1 | 12 |
| 2009 | 6 | 17 |
| 2010 | 5 | 21 |
| 2011 | 7 | 11 |
| 2012 | 7 | 13 |
| 2013 | 7 | 18 |
| 2014 | 9 | 24 |
| 2015 | 10 | 19 |
| 2016 | 13 | 28 |
| 2017 | 15 | 21 |
| 2018 | 15 | 28 |
| 2019 | 17 | 16 |
| 2020 | 14 | 23 |
| 2021 | 10 | 29 |
| 2022 | 14 | 35 |
| 2023 | 10 | 20 |
| 2024 | 6 | 17 |
| 2025 | 14 | 24 |
| 2026 | 12 | 18 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Combination drug for the control and management of type 2 diabetes mellitus6 Oct 2026US 12,751,958 B2Laboratorios Silanes S.A. de C.V.
- Methods of treating ischemic stroke at risk for cerebral or cerebellar edema15 Sep 2026US 12,734,182 B2Remedy Pharmaceuticals, Inc.
- Thromboxane receptor antagonist formulations18 Aug 2026US 12,708,607 B2Atxa Therapeutics Limited
- Allosteric agonists and positive allosteric modulators of Glucagon-like peptide 1 receptor28 Jul 2026US 12,691,118 B2Saint Joseph's University
- Compositions and methods for treating lung injury21 Jul 2026US 12,685,739 B2The United States Government as represented by the Department of Veterans Affairs
- Peptide tyrosine-tyrosine analog and use thereof24 Sep 2026US 2026/0285932 A1The United Bio-Technology (Hengqin) Co., Ltd.
- Herbal composition for metabolic syndromes and method of treatment thereof17 Sep 2026US 2026/0273014 A1
- Potent transthyretin (ttr) stabilization in ttr amyloidosis patients receiving acoramidis20 Aug 2026US 2026/0240815 A1Eidos Therapeutics, Inc.
- Pharmaceutical composition for prevention or treatment of age-related musculoskeletal disorders20 Aug 2026US 2026/0240871 A1Seoul National University R&Db Foundation
- Combination of metformin and glibenclamide in the treatment of parkinson's disease20 Aug 2026US 2026/0240872 A1Cxs Therapeutics
Most cited
By later US patents
- Combinations for diabetes136US 6,011,049 AWarner-Lambert Company · 2000
- Solid compositions containing polyethylene oxide and an active ingredient113US 6,117,453 APharma Pass LLC · 2000
- Delivery system for administration blood-glucose lowering drug107US 5,091,190 AAlza Corporation · 1992
- Solid compositions containing glipizide and polyethylene oxide105US 6,348,469 B1Pharma Pass LLC · 2002
- Sulfonylurea-glitazone combinations for diabetes86US 5,859,037 AWarner-Lambert Company · 1999